Tau: Enabler of diverse brain disorders and target of rapidly evolving therapeutic strategies

Chang, Che-Wei, Shao, Eric, Mucke, Lennart·2021·Science

Cited by (265)

Items 101–200 of 265

  1. Microtubule‐affinity regulating kinase family members distinctively affect tau phosphorylation and promote its toxicity in a Drosophila model
    Grigorii Sultanakhmetov, Iori Kato, Akiko Asada, Taro Saito, Kanae Ando · 2024 · Genes to Cells
  2. Phenotypic Differences between the Alzheimer’s Disease-Related hAPP-J20 Model and HeterozygousZbtb20Knock-Out Mice
    Daniel R. Gulbranson, Kaitlyn Ho, Gui-Qiu Yu, Xinxing Yu, Melanie M. Das, Eric Shao, Daniel Kim, Weiping J. Zhang, Krishna Choudhary, Reuben Thomas et al. · 2021 · eNeuro
  3. Jiedu Yizhi Formula Improves Cognitive Function by Regulating the Gut Dysbiosis and TLR4/NF-κB Signaling Pathway
    Pengqi Zhang, Tianye Wang, Xiaoting Zhu, Lina Feng, Jiale Wang, Yunqiang Li, Xinyue Zhang, Tingting Cui, Mingquan Li · 2023 · Neuropsychiatric Disease and Treatment
  4. Sut-6/NIPP1 modulates tau toxicity
    Rebecca L. Kow, Aristide H. Black, Bremer Henderson, Brian C. Kraemer · 2023 · Human Molecular Genetics
  5. Lineage-specific splicing regulation of MAPT gene in the primate brain
    Yocelyn Recinos, Suying Bao, Xiaojian Wang, Brittany Lynn Phillips, Yow-Tyng Yeh, Sebastien M. Weyn‐Vanhentenryck, Maurice S. Swanson, Chaolin Zhang · 2024 · Cell Genomics
  6. Current progress in aptamer-based sensors for the detection of protein biomarkers in neurodegenerative diseases
    Tao Cheng, Noshin Afshan, Jianwei Jiao, Jin Jiao · 2024 · Biosensors and Bioelectronics X
  7. Inhibition of soluble epoxide hydrolase confers neuroprotection and restores microglial homeostasis in a tauopathy mouse model
    Shuo Wang, Chuangye Qi, Chetan Singh Rajpurohit, Baijayanti Ghosh, Wen Xiong, Baiping Wang, Yanyan Qi, Sung Hee Hwang, Bruce D. Hammock, Hongjie Li et al. · 2025 · Molecular Neurodegeneration
  8. Tau phosphorylation and OPA1 proteolysis are unrelated events: Implications for Alzheimer's Disease
    Marcel Victor Alavi · 2021 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  9. Differential Effects of Human Tau Isoforms to Neuronal Dysfunction and Toxicity in the Drosophila CNS
    Ergina Vourkou, Vassilis Paspaliaris, Anna Bourouliti, Maria-Christina Zerva, Engie Prifti, Katerina Papanikolopoulou, Efthimios M. C. Skoulakis · 2022 · International Journal of Molecular Sciences
  10. Focus on Alzheimer’s Disease: The Role of Fibroblast Growth Factor 21 and Autophagy
    Lan Yang, Jianfei Nao · 2022 · Neuroscience
  11. Spreading of Tau Protein Does Not Depend on Aggregation Propensity
    Sara Rodrigues, Marta Anglada‐Huguet, Katja Hochgräfe, Senthilvelrajan Kaniyappan, Susanne Wegmann, Eva‐Maria Mandelkow · 2023 · Journal of Molecular Neuroscience
  12. Acetylated tau exacerbates apoptosis by disturbing mitochondrial dynamics in HEK293 cells
    Jun‐Fei Zhang, Zhi‐Ting Fang, Jun‐Ning Zhao, Gong‐Ping Liu, Xin Shen, Gaofeng Jiang, Qian Rong Liu · 2024 · Journal of Neurochemistry
  13. Dynamic-Inspired Perspective on the Molecular Inhibitor of Tau Aggregation by Glucose Gallates Based on Human Neurons
    Yuan Hu, Danjing Yang, Ying Tu, Keke Chai, Lei Chu, Shuo Shi, Tianming Yao · 2021 · ACS Chemical Neuroscience
  14. Tau P301L mutation promotes core 4R tauopathy fibril fold through near-surface water structuring and conformational rearrangement
    Michael P. Vigers, Samuel Lobo, Saeed Najafi, Austin DuBose, Karen Tsay, Pritam Ganguly, Andrew P. Longhini, Yingying Jin, Steven K. Buratto, Kenneth S. Kosik et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  15. Elevated SGK1 increases Tau phosphorylation and microtubule instability in Alzheimer’s patient-derived cortical neurons
    Saleem, Komal, Xiao, Zichun, Zhu, Binglin, Ren, Yong, Yan, Zhen, Feng, Jian · 2026 · Molecular Psychiatry
  16. Combating multiple aetiologies of Alzheimer's disease to rescue behavioural deficits
    Madhu Ramesh, Chenikkayala Balachandra, Ashish Kumar, Sourav Samanta, Thimmaiah Govindaraju · 2025 · Chemical Science
  17. Neuronal APOE4-induced early hippocampal network hyperexcitability in Alzheimer’s disease pathogenesis
    Dennis R. Tabuena, Sung-Soo Jang, Brian P. Grone, Oscar Yip, Emily A Aery Jones, Jessica R. Blumenfeld, Zherui Liang, Rajkamalpreet S. Mann, Yaqiao Li, Deanna Necula et al. · 2026 · Nature Aging
  18. TNAP upregulation is a critical factor in Tauopathies and its blockade ameliorates neurotoxicity and increases life-expectancy
    Álvaro Sebastián‐Serrano, Jesús Merchán‐Rubira, Caterina Di Lauro, Carolina Bianchi, Lucía Soria-Tobar, Sonoko Narisawa, José Luís Millán, Jesús Ávila, Félix Hernández, Miguel Dı́az-Hernández · 2022 · Neurobiology of Disease
  19. An adeno-associated virus-mediated immunotherapy for Alzheimer’s disease
    Yu Zhang, Qian Lin, Yuzhu Kuang, Junting Liu, Diqi Wang, Wenqi Xie, Linbo Zhang, Lu Fu · 2022 · Molecular Immunology
  20. Melissa officinalis extract suppresses endoplasmic reticulum stress-induced apoptosis in the brain of hypothyroidism-induced rats exposed to γ-radiation
    Omayma AR Abo-Zaid, Fatma SM Moawed, Eman F. S. Taha, Esraa S. A. Ahmed, Ragaa SM Kawara · 2023 · Cell Stress and Chaperones
  21. Dual role of IRE1α-XBP1 signaling in neurodegenerative diseases.
    Cai-Lin Wang, Yanmin Chang, Jia-Hui Zhu, Rong Ma, Gang Li · 2022 · Neuroscience
  22. Benzothiazole Substitution Analogs of Rhodacyanine Hsp70 Inhibitors Modulate Tau Accumulation
    Shannon E. Hill, David Beaulieu‐Abdelahad, Andrea Lemus, Jack M. Webster, Santiago Rodriguez Ospina, April L. Darling, Mackenzie D. Martin, Shreya Patel, Liznair Bridenstine, Ronald Swonger et al. · 2023 · ACS Chemical Biology
  23. Interaction Between a High-Fat Diet and Tau Pathology in Mice: Implications for Alzheimer’s Disease
    Yu Jung Jang, Min Gyu Choi, Byung Jae Yoo, Kyeong Jae Lee, Won Beom Jung, Seong‐Gi Kim, Sun Ah Park · 2023 · Journal of Alzheimer s Disease
  24. A pathogenic Tau mutation drives autophagy-lysosome dysfunction that limits Tau degradation in a model of frontotemporal dementia
    Farzaneh Sadat Mirfakhar, Jacob A. Marsh, Chihiro Sato, Kylie J. Schache, Miguel Minaya, Roland E. Dolle, Stephen C. Pak, Gary A. Silverman, David H. Perlmutter, Shannon L. Macauley et al. · 2026 · Nature Communications
  25. Non-human Primate Models of Alzheimer’s Disease
    Yihan Li, Ben J. Gu · 2023 · Journal of Exploratory Research in Pharmacology
  26. DLK-MAPK Signaling Coupled with DNA Damage Promotes Intrinsic Neurotoxicity Associated with Non-Mutated Tau
    Sanming Li, Ethan R. Roy, Yanyu Wang, Trent A. Watkins, Wei Cao · 2023 · Molecular Neurobiology
  27. Immunoproteasome deficiency results in age-dependent development of epilepsy
    Hanna Leister, Felix F. Krause, Beatriz Gil, Ruslan Prus, Inna Prus, Anne Hellhund, Meghma Mitra, Rogério R. Gerbatin, Norman Delanty, Alan Beausang et al. · 2023 · Brain Communications
  28. Focusing on oligomeric tau as a therapeutic target in Alzheimer’s disease and other tauopathies
    Joseph B. Rayman · 2023 · Expert Opinion on Therapeutic Targets
  29. Spotlight on mechanism of sudden unexpected death in epilepsy in Dravet syndrome
    WeiHui Shao, Lu Liu, JiaXuan Gu, Yue Yang, YaXuan Wu, ZhuoYue Zhang, Qing Yang Xu, Yuling Wang, Yue Liang Shen, LeYuan Gu et al. · 2025 · Translational Psychiatry
  30. Short-chain polyphosphates induce tau fibrillation and neurotoxicity in human iPSC-derived retinal neurons
    2025
  31. Long-Term Depression-Inducing Low Frequency Stimulation Enhances p-Tau181 and p-Tau217 in an Age-Dependent Manner in Live Rats
    Yangyang Zhang, Yin Yang, Zhengtao Hu, Manyi Zhu, Shuangying Qin, Pengpeng Yu, Bo Li, Ji‐Tian Xu, Tomáš Ondrejčák, Igor V. Klyubin et al. · 2022 · Journal of Alzheimer s Disease
  32. Prenatal PM2.5 exposure contributes to neuronal tau lesion in male offspring mice through mitochondrial dysfunction-mediated insulin resistance
    Yanwen Hou, Wei Wei, Guangke Li, Nan Sang · 2022 · Ecotoxicology and Environmental Safety
  33. Deciphering the endogenous SUMO-1 landscape: a novel combinatorial peptide enrichment strategy for global profiling and disease association
    Xiaoyu Zhang, Bowen Zhong, Yue Sun, Dan Liu, Xiancheng Zhang, Dongdong Wang, Cunli Wang, Huiling Gao, Manli Zhong, Haijuan Qin et al. · 2024 · Chemical Science
  34. PROTAC technology for prostate cancer treatment
    Zhen Wang, Dingpeng Zhang, Hiroyuki Inuzuka, Wenyi Wei · 2025 · Acta Materia Medica
  35. Functional Cooperation of α-Synuclein and Tau Is Essential for Proper Corticogenesis
    Shengming Wang, Yu Fu, Takaki Miyata, Sakiko Matsumoto, Tomoyasu Shinoda, Kyoko Itoh, Akihiro Harada, Shinji Hirotsune, Mingyue Jin · 2022 · Journal of Neuroscience
  36. ApoE and immunity in Alzheimer’s disease and related tauopathies: Low-density lipoprotein receptor to the rescue
    Andrew S. Mendiola, Reshmi Tognatta, Zhaoqi Yan, Katerina Akassoglou · 2021 · Neuron
  37. Tau reduction with artificial microRNAs modulates neuronal physiology and improves tauopathy phenotypes in mice
    C. Facal, Iván Fernández Bessone, J. Muñiz, A. Pereyra, Olivia Pedroncini, Indiana Páez-Paz, Ramiro Clerici-Delville, Cayetana Arnaiz, Leandro Urrutia, G. Falasco et al. · 2024 · Molecular Therapy
  38. Internal-driven DNA nanowindmill: Multi-fulcrum mediated amplified rolling nanomachine for fast and ultrasensitive electrochemical detection of tau
    Tao Cheng, Ke Jiao, Mingyang Sun, Jiabao Yu, Jin Jiao, Jin Jiao · 2024 · Sensors and Actuators B Chemical
  39. Harnessing artificial intelligence for brain disease: advances in diagnosis, drug discovery, and closed-loop therapeutics
    Su-jun Fang, Zhao-di Yin, Qi Cai, Lifan Li, Peng-fei Zheng, Lizhen Chen · 2025 · Frontiers in Neurology
  40. Tau post-translational modifications in Alzheimer's disease: Insights into pathogenesis, therapeutic strategies, and diagnostic advances
    Hui Lei, Xiaohua Chen, Longzhu Ruan, Xuena Liu, Fei Ye, Kejing Li, Wei Cheng, Boyi Yu, Cuixia Di, Cuixia Di · 2025 · Ageing Research Reviews
  41. Enlarged perivascular spaces in the basal ganglia across epilepsy subtypes
    Benjamin Sinclair, Clarissa Lin Yasuda, John‐Paul Nicolo, Gernot Hlauschek, Thais Maria Santos Bezerra, Zhibin ZC Chen, Lucy E. Vivash, Brunno Machado de Campos, Rafael Batista João, Ricardo Brioschi et al. · 2025 · Epilepsia
  42. Tau phosphorylation homeostasis: Mechanisms, targets, and therapeutic implications in Alzheimer’s disease
    ShengWen Lu, Shi Qiu, Guan Yu, Aihua Zhang, Qiqi Zhao · 2026 · Ageing Research Reviews
  43. Total alkaloids from the seed embryo of Nelumbo nucifera Gaertn. improve cognitive impairment in APP/PS1 mice and protect Aβ-damaged PC12 cells
    Xue‐Lian Meng, Jing‐Su Xue, Shu-Jie Su, Jiang‐Min Gou, Jing Lu, Chang-Lan Chen, Chengbin Xu · 2022 · Nutritional Neuroscience
  44. Syk inhibitors reduce tau protein phosphorylation and oligomerization
    Tomohisa Yamaguchi, Tadanori Hamano, Kiyonao Sada, Rei Asano, Nicholas M. Kanaan, Hirohito Sasaki, Shu-Hui C. Yen, Yuki Kitazaki, Yoshinori Endo, Soichi Enomoto et al. · 2024 · Neurobiology of Disease
  45. Patient-derived tau and amyloid-β facilitate long-term depression in vivo: role of tumour necrosis factor-α and the integrated stress response
    Neng‐Wei Hu, Tomáš Ondrejčák, Igor V. Klyubin, Yin Yang, Dominic M. Walsh, Frederick J. Livesey, Michael J. Rowan · 2024 · Brain Communications
  46. The prevalence of chronic traumatic encephalopathy in a historical epilepsy post‐mortem collection
    Maritchka Ryniejska, Hanaa El Hachami, Alicja Mrzyglod, Joan Y. W. Liu, Maria Thom · 2024 · Brain Pathology
  47. Designed Cell-Penetrating Peptide Constructs for Inhibition of Pathogenic Protein Self-Assembly
    Mona Kalmouni, Yujeong Oh, Waël Alata, Mazin M. Magzoub · 2024 · Pharmaceutics
  48. Active immunization in Alzheimer’s disease
    Douglas R Galasko · 2021 · Nature Aging
  49. Tau deficiency inhibits classically activated macrophage polarization and protects against collagen-induced arthritis in mice
    Meng Chen, Wenyu Fu, Huiyun Xu, C.-J. Liu · 2023 · Arthritis Research & Therapy
  50. ApoE ε4-dependent Alteration of CXCR3 + CD127+ CD4+ T cells associates with elevated plasma neurofilament light chain in Alzheimer's disease
    Dan Hu, Mei Chen, Xu-Yang Li, S. Daley, Peter Morin, Yuyang Han, M. Hemberg, H. Weiner, Wei-Ming Xia · 2025 · Journal of Alzheimer's Disease
  51. Bezafibrate treatment rescues neurodevelopmental and neurodegenerative defects in 3D cortical organoid model of MAPT frontotemporal dementia
    Federica Cordella, Lorenza Mautone, Debora Salerno, Lucrezia Tondo, Silvia Ghirga, Chiara D’Antoni, Erika Parente, Maria Anele Romeo, Mara Cirone, Paola Bezzi et al. · 2025 · Alzheimer s & Dementia
  52. Pharmacological action, mechanism and structure-activity relationship of traditional Chinese medicine polysaccharide in the treatment of Alzheimer's disease: A review
    Jinsuo Zhou, Xingyu Guo, Wenting Yu, Huinan Bu, Yongqiang Du, Shanshan Li, Haixue Kuang, Lun Wu · 2025 · International Journal of Biological Macromolecules
  53. The MIR-NAT MAPT-AS1 does not regulate Tau expression in human neurons
    Rafaela Policarpo, Leen Wolfs, Saúl Martínez‐Montero, Lina Vandermeulen, Ines E. Royaux, Gert Van Peer, Pieter Mestdagh, Annerieke S. R. Sierksma, Bart De Strooper, Constantin van Outryve d’Ydewalle · 2025 · PLoS ONE
  54. Autophagy and tau protein
    Tadanori Hamano, Yoshinori Endo · 2022 · Elsevier eBooks
  55. Opportunities for Cellular Rejuvenation in Alzheimer's Disease: How Epigenetic Reprogramming and Chaperone-Mediated Autophagy Are Enabling Next Generation Therapeutic Approaches
    Sharon J. Rosenzweig-Lipson · 2023 · The Journal of Prevention of Alzheimer s Disease
  56. Preclinical Evidence for the Role of the Yin/Yang Angiotensin System Components in Autism Spectrum Disorder: A Therapeutic Target of Astaxanthin
    Ayat I. Samra, Ahmed Seif El Din Kamel, Dalaal M. Abdallah, Mai A. Abd El Fattah, Kawkab A. Ahmed, Hanan Salah El-Abhar · 2023 · Biomedicines
  57. DUB’ling down uncovers an X-linked vulnerability in Alzheimer’s disease
    Bindu Diana Paul · 2022 · Cell
  58. Tau depletion diminishes vascular amyloid-related deficits in a mouse model of cerebral amyloid angiopathy
    Jury‐Garfe, Nur, Chimal‐Juárez, Enrique, Patel, Henika, Martinez‐Pinto, Jonathan, Vanderbosch, Kathryn, Mardones, Muriel D., Perkins, Abigail, Prisco, Gonzalo Viana Di, Marambio, Yamil, Vidal, Ruben et al. · 2025 · Alzheimer's & Dementia
  59. Research progress on the relationship between epilepsy and circRNA
    Jinxia Zhai, Chao Wang, Liang Jin, Mingjie Liu, Yongjun Chen · 2024 · Brain Research
  60. Understanding retinal tau pathology through functional 2D and 3D iPSC-derived in vitro retinal models
    Lorenza Mautone, Federica Cordella, Alessandro Soloperto, Silvia Ghirga, Giorgia Di Gennaro, Ylenia Gigante, Silvia Di Angelantonio · 2025 · Acta Neuropathologica Communications
  61. Superhydrophilic Nanostructured Microparticles for Enhanced Phosphoprotein Enrichment from Alzheimer’s Disease Brain
    Danyi Shang, Yongyang Song, Yun Cui, Cheng Chen, Feifei Xu, Congcong Zhu, Xuefang Dong, Yifan Chen, Shutao Wang, Xiuling Li et al. · 2025 · ACS Nano
  62. Identification of image genetic biomarkers of Alzheimer's disease by orthogonal structured sparse canonical correlation analysis based on a diagnostic information fusion
    Wei Yin, Yang Tao, GuangYu Wan, Xiong Hui Zhou · 2023 · Mathematical Biosciences & Engineering
  63. The neuroinflammatory role of microRNAs in Alzheimer’s disease: pathological insights to therapeutic potential
    Wenjia Liu, Xin Rao, Wen Sun, Xiaodong Chen, Liyang Yu, Jiangtao Zhang, Jiong Chen, Xiaorong Zheng · 2024 · Molecular and Cellular Biochemistry
  64. Proteomic Assessment of C57BL/6 Hippocampi after Non-Selective Pharmacological Inhibition of Nitric Oxide Synthase Activity: Implications of Seizure-like Neuronal Hyperexcitability Followed by Tauopathy
    Jhana O. Hendrickx, Charlotte Adams, Anne Sieben, Kris Laukens, Debby Van Dam, Guido R.Y. De Meyer · 2022 · Biomedicines
  65. Advancing Alzheimer’s research by improving disease modeling of secondary tauopathy
    Ethan R. Roy, Wei Cao · 2025 · npj Dementia
  66. Unraveling APOE4's Role in Alzheimer's Disease: Pathologies and Therapeutic Strategies
    Siddhant Tripathi, Yashika Sharma, Dileep Kumar · 2024 · Current Protein and Peptide Science
  67. Multi-omic phenotyping of MAPT V337M neurons reveals early changes in axonogenesis and tau phosphorylation
    Gregory A. Mohl, Gary Dixon, Emily Marzette, Justin McKetney, Avi J. Samelson, Carlota Pereda Serras, Julianne Jin, Nabeela Ariqat, Andrea Keys, Cristian Chavira et al. · 2026 · npj Dementia
  68. High Level Forebrain Expression of Active Tau Kinase p38γ Exacerbates Cognitive Dysfunction in Aged APP-transgenic Alzheimer’s Mice
    Prita Riana Asih, Kristie Stefanoska, Emmanuel Prikas, Arne Ittner · 2022 · Neuroscience
  69. Molecular-level interplay between intrinsically disordered clients and Hsp90
    Lisa Marie Ramirez, Markus Zweckstetter · 2023 · Current Opinion in Chemical Biology
  70. The role of peptidyl-prolyl isomerase Pin1 in neuronal signaling in epilepsy
    Yuwen Chen, Xiaojun Hou, Jiao Pang, Fan Yang, Angcheng Li, Suijin Lin, Na Lin, Tae Ho Lee, Hekun Liu · 2022 · Frontiers in Molecular Neuroscience
  71. Mechanisms and targeted treatments of cobalt-encephalopathy from cobalt-chromium orthopedic implants.
    Tong Wu, Hao-Ran Li, Wu Chen · 2025 · Neuroscience
  72. Gut Microbiome–Sphingolipid Metabolism–Brain Axis Interactions: Neuroprotective Effects of Amitriptyline as Functional Inhibitor of Acid Sphingomyelinase in a Mouse Model of Tauopathy
    Mennatallah Ibrahim, Asmaa M. Khalil, Heba Attia, Saleh Alseekh, Ahmed F. Mohamed, Mohammed F. El-Yamany · 2026 · Journal of Neuroimmune Pharmacology
  73. The Cellular Environment Guides Self‐Assembly and Structural Conformations of Microtubule‐Associated Protein Tau (MAPT)
    Kelly M. Montgomery, Avi J. Samelson, Jason E. Gestwicki · 2023 · Israel Journal of Chemistry
  74. Discovery of penicillic acid as a chemical probe against tau aggregation in Alzheimer's disease
    Jennifer Shyong, Jinliang Wang, Quoc-Dung Tran Huynh, Marina Fayzullina, Bo Yuan, Ching‐Kuo Lee, Thomas G. Minehan, Paul M. Seidler, Clay C. C. Wang · 2024 · Chemical Science
  75. Preoperative Plasma p-tau231, p-tau181, and p-tau217 Are Associated With Postoperative Delirium: A Prospective Study
    LiXue Wu, JiaBao Su, Guangping Li, Meng Zhuang, HaiJian Sun, Jiru Zhang · 2025 · The Journals of Gerontology Series A
  76. Non-mutated human tau stimulates Alzheimer’s disease-relevant neurodegeneration in a microglia-dependent manner
    Ethan R. Roy, Qiang Wang, Kexin Huang, Sanming Li, Yuanyuan Fan, Estrella Escobar, Constance Lynn Atkins, Shuning Huang, Juan J. Herrera, Wenbo Li et al. · 2025 · Scientific Reports
  77. Disentangling the role of tau pathology in autism spectrum disorders
    Francisca Villavicencio-Tejo, Margrethe A. Olesen, M. Leonardo Moya, Rodrigo A. Quintanilla · 2025 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  78. Top 100 most-cited articles on tau protein: a bibliometric analysis and evidence mapping
    Zheping Chen, Guoliang Shan, Xinyue Wang, Yaqun Zuo, Xinyu Song, Yufeng Ma, Xin Zhao, Yanwu Jin · 2024 · Frontiers in Neuroscience
  79. Patterns of phosphorylated tau accumulation in a spectrum of acquired and developmental brain lesions associated with refractory epilepsy
    Alicja Mrzyglod, Anya Mebrouk, Joanna Bartkiewicz, Hanaa El Hachami, Maritchka Ryniejska, Jane de Tisi, Roland Coras, Ingmar Blümcke, Fenglai Xiao, Anna Miserocchi et al. · 2025 · Epilepsia
  80. Methods for high throughput discovery of fluoroprobes that recognize tau fibril polymorphs
    Emma C. Carroll, Hyunjun Yang, Julia G. Jones, Abby Oehler, Annemarie F. Charvat, Kelly Montgomery, Anthony Yung, Zoe Millbern, Nelson R. Vinueza, William F. DeGrado et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  81. Reevaluating tau reduction as a therapeutic approach for tauopathies: Insights and perspectives
    Xiaohuan Sun, Victor C. Ogbolu, Peter W. Baas, Liang Qiang · 2023 · Cytoskeleton
  82. BMAL1 in Astrocytes: A Protective Role in Alzheimer’s and Parkinson’s Disease
    David Brash-Arias, Luis I. García, Gonzálo Emiliano Aranda-Abreu, María Rebeca Toledo‐Cárdenas, César Antonio Pérez-Estudillo, Donají Chi-Castañeda · 2025 · Neuroglia
  83. Nucleotide Metabolism and Immune Genes Can Predict the Prognostic Risk of Hepatocellular Carcinoma and the Immune Microenvironment
    Xiaofang Wang, Qinghua Cui, Yuan M. Zhou · 2025 · Biology
  84. Selective degradation of DAPK1 via a novel hydrophobic tagging attenuates tau pathology in Alzheimer’s disease
    Ruomeng Li, Xueyin Wu, Jing Yao, Jiawen Chen, Xindong Shui, Xiaoqing Zheng, Wujin Tian, Long Wang, Ying Zhou, Tao Zhang et al. · 2025 · Journal of Advanced Research
  85. Glycoengineered Host-Guest Nanoparticles Potentiate Alzheimer’s Disease Therapy via Lesion-Specific Modulation of Tau Pathology
    Yi Lai, Jiaxing Pan, Yuejiao Gu, Chuan Zhou, Wenfang Yang, Qian Zhao, Zifan Zhu, Yanhong Duan, Li Lei, Ying Fu et al. · 2026 · Journal of the American Chemical Society
  86. Tau-induced mitochondrial reverse electron transport drives neurodegeneration
    Wen Li, Suman Rimal, Sunil Bhurtel, Lucas Yeung, Benjamin G. Lu, Lea T. Grinberg, Salvatore Spina, Inma Cobos, William W. Seeley, Su Guo et al. · 2026 · Neuron
  87. Nanopore‐Based High‐Resolution Detection of Multiple Post‐Translational Modifications in Protein
    Ziyi Li, Yakun Yi, Yun Zhang, Yuanyuan Xiao, Qianyuan Ren, Ke Zhou, Lei Liu, Hai‐Chen Wu · 2025 · Angewandte Chemie
  88. The complex enigma of tau
    Masud Husain B · 2021 · Brain
  89. Tau in Health and Neurodegenerative Diseases
    Dandan Chu, Fei Liu · 2021 · IntechOpen eBooks
  90. Altern und neurodegenerative Erkrankungen – warum gehen Nervenzellen verloren?
    Lars P. Klimaschewski · 2021 · Springer eBooks
  91. Tau modulates nuclear integrity, chromatin, and cholesterol synthesis genes via the nuclear envelope
    Lisa Diez, Renata Ponce-Lina, Cagla Kilic, Rithika Sankar, Frieda Balduin, Cong Wang, Pia Grundschöttel, Koki Sakurai, Bilge Askin, Chiara Bordier et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  92. Pad2 deletion induces anxiety‑like behaviors and memory deficits in mice
    Xiaoqiang Lv, Hui Deng, Cunzhi Li, Wenzhi Gao, Yuhao Zhang, Yongchao Gao, Bin Zhao, Changhong Shi, Junhong Gao, Zhiyong Liu · 2025 · Brain Research Bulletin
  93. New biomarkers for early-stage tau pathology in Alzheimer’s disease
    Rongcan Luo, Jin‐Tai Yu · 2025 · Nature Aging
  94. Synaptotoxic effects of extracellular tau are mediated by its microtubule-binding region
    Tomáš Ondrejčák, Neng‐Wei Hu, Emily Coode, Tom Campbell, Grant T. Corbett, Ivan Doykov, Kevin A. Mills, Dominic M. Walsh, Frederick J. Livesey, Michael J. Rowan et al. · 2025 · Acta Neuropathologica
  95. Stathmin 1 regulates epileptic seizures by influencing GABAA R-mediated inhibitory synaptic activity
    Mi Yang, Yida David Hu, Junhong Wu, Haitao Zhang, Juan Li, Wang Xuefeng, Xin Xu · 2026 · Neurobiology of Disease
  96. α,β-Dehydroamino-Acid-Containing Peptides Resist Proteolysis and Inhibit Aggregation of a Tau-Derived Model Peptide
    Stephanie G Garcia, Ahmad Abdullatif Almardini, Aramis J. Pereira, Huihua Xing, Logan J Knox, Julie V Jimenez, Joshua C Webster-Ford, Diego A. Moyá, Joshua C. Payne, Courtney K Dawes et al. · 2026 · The Journal of Organic Chemistry
  97. Tau T205 phosphorylation modulates engram cell recruitment and remote memory in mice
    Renée Kosonen, Kristie Stefanoska, Yijun Lin, Samantha Edwards, Emmanuel Prikas, Josefine Bertz, Anne Poljak, Lars Matthias Ittner, Arne Ittner · 2026 · Nature Communications
  98. Herbal Neurotherapeutics for Cognitive Disorders: Integrative Mechanisms Linking Neurotransmitter Systems, Neurodegeneration, and the Gut-Brain Axis
    Muntajin Rahman, Khadija Akter, Amama Rani, Moon Nyeo Park, Bonglee Kim · 2026 · Nutrients
  99. Emerging New Pathways in Malignant Neoplasms and Neurodegenerative Disorders: Perspectives for Therapeutics
    Wolf Wrasidlo, Eliezer Masliah · 2026 · Cells
  100. Aging and Neurodegenerative Diseases: Why do Nerve Cells Die?
    Lars P. Klimaschewski · 2022 · Springer eBooks